Clinical Trial: Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444164) titled 'Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.' on Feb. 24.

Brief Summary: Study conducted to determine and compare the relative bioavailability of two solid oral formulations (reference versus test) of the non-fixed combination of Ticagrelor 90 mg (Brilinta by AstraZeneca S.A. de C.V.) + Acetylsalicylic Acid 100 mg (ASPIRINA JUNIOR by Bayer de Mexico S.A. de C.V.) administered concomitantly versus the fixed-dose combination of Ticagrelor 90 mg / Acetylsalicylic Acid 100 mg manufactured by Laboratorios Silanes S.A. de C.V.

Study Start Date: Jan. 13, 2025

Study Type: INTERV...